Tokio Marine Asset Management Co. Ltd. Grows Stock Position in CME Group Inc. (NASDAQ:CME)

Tokio Marine Asset Management Co. Ltd. boosted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,836 shares of the financial services provider’s stock after buying an additional 152 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in CME Group were worth $2,284,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Meyer Handelman Co. bought a new position in CME Group during the 4th quarter valued at about $6,144,000. Worldquant Millennium Advisors LLC boosted its position in shares of CME Group by 58.4% during the third quarter. Worldquant Millennium Advisors LLC now owns 613,828 shares of the financial services provider’s stock valued at $135,441,000 after buying an additional 226,306 shares during the period. Geode Capital Management LLC grew its stake in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after buying an additional 142,692 shares during the last quarter. Bank of Montreal Can raised its holdings in shares of CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after buying an additional 303,169 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its stake in shares of CME Group by 18.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,826,501 shares of the financial services provider’s stock worth $403,017,000 after acquiring an additional 283,171 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Keefe, Bruyette & Woods dropped their target price on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a research note on Monday, January 13th. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Barclays increased their price objective on CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research note on Monday, December 9th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $229.27.

Check Out Our Latest Report on CME Group

CME Group Price Performance

CME opened at $236.52 on Monday. The firm has a market capitalization of $85.23 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 5.28 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50-day moving average is $234.73 and its two-hundred day moving average is $222.63. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $249.02.

CME Group Increases Dividend

The company also recently disclosed a dividend, which was paid on Thursday, January 16th. Investors of record on Friday, December 27th were paid a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s payout ratio is 48.37%.

CME Group declared that its board has initiated a stock buyback program on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s management believes its shares are undervalued.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.